Liraglutide


( Last Updated : November 29, 2010)
Generic Name:
Liraglutide
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, Type 2
Manufacturer:
Novo Nordisk Canada Inc.
Call for patient/clinician input open:
Brand Name:
Victoza
Project Line:
Reimbursement Review
Project Number:
SR0217-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Diabetes mellitus, Type 2
Recommendation Type:
Do not list
Final Recommendation: